Wild-type p53 enhances the cytotoxic effect of radionuclide gene therapy using sodium iodide symporter in a murine anaplastic thyroid cancer ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2009-09-01

AUTHORS

Yong Jin Lee, June-Key Chung, Joo Hyun Kang, Jae Min Jeong, Dong Soo Lee, Myung Chul Lee

ABSTRACT

PurposeTo evaluate the role of p53 in radionuclide gene therapy, we investigated the cytotoxic effect of 131I and 188Re following cotransfection of the sodium iodide symporter (NIS) and wild-type p53 (wt-p53) genes into cancer cells.MethodsThe NIS gene was transfected to human anaplastic thyroid carcinoma cells (ARO) expressing mutant p53 (mt-p53) using liposomes. The uptakes of 125I and 188Re were measured in the transfected (ARO-N) and wild-type cell lines (ARO). A recombinant adenovirus-5 vector containing a CMV promoter and wt-p53 cDNA, called Ad-p53, was established and transduced to ARO and ARO-N cells. After incubating cells with 131I and 188Re, the survival rate of each cell line was measured using a clonogenic assay. For radionuclide gene therapy in an animal model, Ad-p53 was injected directly into ARO and ARO-N tumours which were transplanted to nude mice. Two days later, 188Re or saline was injected intraperitoneally into the mice, and the tumours were measured using a calliper for 4 weeks.ResultsIn ARO-N cells, the uptakes of 125I and 188Re were 505.16±21.30 pmol/106 cells and 13,875.20±504.85 cpm/106 cells at 30 min, respectively. There was no difference between the survival rates of ARO cells and ARO-N cells after incubation with 131I or 188Re. When Ad-p53 was transduced to ARO-N cells, the survival rate of wt-p53-expressing ARO-N cells incubated with 131I (18.5 MBq/5 ml) and 188Re (18.5 MBq/5 ml) decreased to 48.8±18.4% and 32.6±23.5%, respectively. In the nude mice experiment, ARO and ARO-N tumours gradually grew up to six to eight times larger than the initial volume. ARO and ARO-N tumours transduced with Ad-p53 continued to grow. However, the ARO-N tumours treated with Ad-p53 and 185 MBq of 188Re regressed to 20% of the initial volume.ConclusionGrowth of ARO-N tumour treated with 131I or 188Re was significantly inhibited by Ad-p53 transduction in vivo as well as in vitro. Transfection of the NIS gene into human anaplastic thyroid cancer induced the accumulation of beta-emitter radionuclides, and cotransfection with a wt-p53 gene enhanced the cytotoxic effect. More... »

PAGES

235-241

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00259-009-1251-5

DOI

http://dx.doi.org/10.1007/s00259-009-1251-5

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1044717502

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/19727716


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Line, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Combined Modality Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease Models, Animal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Genetic Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice, Nude", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radioisotopes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radiopharmaceuticals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Symporters", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thyroid Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Suppressor Protein p53", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Molecular Imaging Research Center, Korea Institute of Radiological and Medical Sciences, 75 Nowon-gil, Gongneung-Dong, 139-706, Nowon-Gu, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.415464.6", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University College of Medicine, 28 Yungun-dong, 110-744, Chongno-gu, Seoul, Korea", 
            "Cancer Research Institute, Seoul National University College of Medicine, 28 Yungun-dong, 110-744, Chongno-gu, Seoul, Korea", 
            "Tumor Immunity Medical Research Center, Seoul National University College of Medicine, 28 Yungun-dong, 110-744, Chongno-gu, Seoul, Korea", 
            "Molecular Imaging Research Center, Korea Institute of Radiological and Medical Sciences, 75 Nowon-gil, Gongneung-Dong, 139-706, Nowon-Gu, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "Yong Jin", 
        "id": "sg:person.0724572466.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0724572466.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Tumor Immunity Medical Research Center, Seoul National University College of Medicine, 28 Yungun-dong, 110-744, Chongno-gu, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University College of Medicine, 28 Yungun-dong, 110-744, Chongno-gu, Seoul, Korea", 
            "Cancer Research Institute, Seoul National University College of Medicine, 28 Yungun-dong, 110-744, Chongno-gu, Seoul, Korea", 
            "Tumor Immunity Medical Research Center, Seoul National University College of Medicine, 28 Yungun-dong, 110-744, Chongno-gu, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chung", 
        "givenName": "June-Key", 
        "id": "sg:person.0751347234.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0751347234.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Molecular Imaging Research Center, Korea Institute of Radiological and Medical Sciences, 75 Nowon-gil, Gongneung-Dong, 139-706, Nowon-Gu, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.415464.6", 
          "name": [
            "Molecular Imaging Research Center, Korea Institute of Radiological and Medical Sciences, 75 Nowon-gil, Gongneung-Dong, 139-706, Nowon-Gu, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kang", 
        "givenName": "Joo Hyun", 
        "id": "sg:person.01356373637.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01356373637.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cancer Research Institute, Seoul National University College of Medicine, 28 Yungun-dong, 110-744, Chongno-gu, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University College of Medicine, 28 Yungun-dong, 110-744, Chongno-gu, Seoul, Korea", 
            "Cancer Research Institute, Seoul National University College of Medicine, 28 Yungun-dong, 110-744, Chongno-gu, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jeong", 
        "givenName": "Jae Min", 
        "id": "sg:person.01301360400.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01301360400.94"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nuclear Medicine, Seoul National University College of Medicine, 28 Yungun-dong, 110-744, Chongno-gu, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University College of Medicine, 28 Yungun-dong, 110-744, Chongno-gu, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "Dong Soo", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nuclear Medicine, Seoul National University College of Medicine, 28 Yungun-dong, 110-744, Chongno-gu, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University College of Medicine, 28 Yungun-dong, 110-744, Chongno-gu, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "Myung Chul", 
        "id": "sg:person.01337220140.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01337220140.25"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/sj.bjc.6602622", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011707440", 
          "https://doi.org/10.1038/sj.bjc.6602622"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.cgt.7700525", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001518423", 
          "https://doi.org/10.1038/sj.cgt.7700525"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.cgt.7700354", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022464572", 
          "https://doi.org/10.1038/sj.cgt.7700354"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1996.101", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004010544", 
          "https://doi.org/10.1038/bjc.1996.101"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2009-09-01", 
    "datePublishedReg": "2009-09-01", 
    "description": "PurposeTo evaluate the role of p53 in radionuclide gene therapy, we investigated the cytotoxic effect of 131I and 188Re following cotransfection of the sodium iodide symporter (NIS) and wild-type p53 (wt-p53) genes into cancer cells.MethodsThe NIS gene was transfected to human anaplastic thyroid carcinoma cells (ARO) expressing mutant p53 (mt-p53) using liposomes. The uptakes of 125I and 188Re were measured in the transfected (ARO-N) and wild-type cell lines (ARO). A recombinant adenovirus-5 vector containing a CMV promoter and wt-p53 cDNA, called Ad-p53, was established and transduced to ARO and ARO-N cells. After incubating cells with 131I and 188Re, the survival rate of each cell line was measured using a clonogenic assay. For radionuclide gene therapy in an animal model, Ad-p53 was injected directly into ARO and ARO-N tumours which were transplanted to nude mice. Two days later, 188Re or saline was injected intraperitoneally into the mice, and the tumours were measured using a calliper for 4\u00a0weeks.ResultsIn ARO-N cells, the uptakes of 125I and 188Re were 505.16\u00b121.30 pmol/106 cells and 13,875.20\u00b1504.85\u00a0cpm/106 cells at 30\u00a0min, respectively. There was no difference between the survival rates of ARO cells and ARO-N cells after incubation with 131I or 188Re. When Ad-p53 was transduced to ARO-N cells, the survival rate of wt-p53-expressing ARO-N cells incubated with 131I (18.5\u00a0MBq/5\u00a0ml) and 188Re (18.5\u00a0MBq/5\u00a0ml) decreased to 48.8\u00b118.4% and 32.6\u00b123.5%, respectively. In the nude mice experiment, ARO and ARO-N tumours gradually grew up to six to eight times larger than the initial volume. ARO and ARO-N tumours transduced with Ad-p53 continued to grow. However, the ARO-N tumours treated with Ad-p53 and 185\u00a0MBq of 188Re regressed to 20% of the initial volume.ConclusionGrowth of ARO-N tumour treated with 131I or 188Re was significantly inhibited by Ad-p53 transduction in vivo as well as in vitro. Transfection of the NIS gene into human anaplastic thyroid cancer induced the accumulation of beta-emitter radionuclides, and cotransfection with a wt-p53 gene enhanced the cytotoxic effect.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00259-009-1251-5", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1297401", 
        "issn": [
          "1619-7070", 
          "1619-7089"
        ], 
        "name": "European Journal of Nuclear Medicine and Molecular Imaging", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "37"
      }
    ], 
    "keywords": [
      "anaplastic thyroid carcinoma cells", 
      "radionuclide gene therapy", 
      "sodium iodide symporter", 
      "survival rate", 
      "cytotoxic effects", 
      "human anaplastic thyroid cancer", 
      "NIS gene", 
      "thyroid cancer model", 
      "human anaplastic thyroid carcinoma cells", 
      "anaplastic thyroid cancer", 
      "gene therapy", 
      "nude mice experiments", 
      "cell lines", 
      "uptake of 125I", 
      "recombinant adenovirus-5 vector", 
      "wt-p53 cDNA", 
      "thyroid carcinoma cells", 
      "adenovirus 5 vector", 
      "role of p53", 
      "wild-type p53 gene", 
      "thyroid cancer", 
      "nude mice", 
      "animal models", 
      "pmol/106 cells", 
      "cancer model", 
      "tumors", 
      "ARO cells", 
      "wild-type p53", 
      "clonogenic assay", 
      "therapy", 
      "carcinoma cells", 
      "wt-p53 gene", 
      "cancer cells", 
      "p53 gene", 
      "mutant p53", 
      "mouse experiments", 
      "wild-type cell lines", 
      "initial volume", 
      "p53", 
      "mice", 
      "CMV promoter", 
      "cells", 
      "beta-emitter radionuclides", 
      "PurposeTo", 
      "cancer", 
      "genes", 
      "cotransfection", 
      "uptake", 
      "symporter", 
      "saline", 
      "weeks", 
      "MBq", 
      "ConclusionGrowth", 
      "rate", 
      "vivo", 
      "effect", 
      "days", 
      "assays", 
      "transfection", 
      "caliper", 
      "volume", 
      "min", 
      "incubation", 
      "differences", 
      "liposomes", 
      "lines", 
      "role", 
      "transduction", 
      "accumulation", 
      "promoter", 
      "cDNA", 
      "time", 
      "model", 
      "radionuclides", 
      "vector", 
      "experiments"
    ], 
    "name": "Wild-type p53 enhances the cytotoxic effect of radionuclide gene therapy using sodium iodide symporter in a murine anaplastic thyroid cancer model", 
    "pagination": "235-241", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1044717502"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00259-009-1251-5"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "19727716"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00259-009-1251-5", 
      "https://app.dimensions.ai/details/publication/pub.1044717502"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-11-24T20:54", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/article/article_485.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00259-009-1251-5"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00259-009-1251-5'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00259-009-1251-5'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00259-009-1251-5'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00259-009-1251-5'


 

This table displays all metadata directly associated to this object as RDF triples.

253 TRIPLES      21 PREDICATES      119 URIs      107 LITERALS      21 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00259-009-1251-5 schema:about N17d21ba2caad4be2a3f83be10952812d
2 N39e9d98b0a78468d9f4a762fec79b692
3 N71139fd63cd94f33af658932537a60ff
4 N7125324fadab489f939f73556b33467f
5 N76b0d495090f43fd9d9e46540776d592
6 N7d452eeb35914675b705436e4701c153
7 N83d34eaf4ee142da8140f03476b0ed50
8 N9d35fb1ce61f4788b2651e91be476fd2
9 Na20eabbf057941be94d0f4cad9d31213
10 Na7eb52409bda4ba1b09bb86925aa3313
11 Nc28c5ac947504b4d9861fb9a980cb1d8
12 Nd4d611619caa4d468151c951df8536f2
13 Ne47d9f0d996b49679dd6620f1de8172e
14 Nfeb393c7726c486595284665886b8ad3
15 anzsrc-for:11
16 anzsrc-for:1112
17 schema:author N45800758971c490da8375cf7d21dc9aa
18 schema:citation sg:pub.10.1038/bjc.1996.101
19 sg:pub.10.1038/sj.bjc.6602622
20 sg:pub.10.1038/sj.cgt.7700354
21 sg:pub.10.1038/sj.cgt.7700525
22 schema:datePublished 2009-09-01
23 schema:datePublishedReg 2009-09-01
24 schema:description PurposeTo evaluate the role of p53 in radionuclide gene therapy, we investigated the cytotoxic effect of 131I and 188Re following cotransfection of the sodium iodide symporter (NIS) and wild-type p53 (wt-p53) genes into cancer cells.MethodsThe NIS gene was transfected to human anaplastic thyroid carcinoma cells (ARO) expressing mutant p53 (mt-p53) using liposomes. The uptakes of 125I and 188Re were measured in the transfected (ARO-N) and wild-type cell lines (ARO). A recombinant adenovirus-5 vector containing a CMV promoter and wt-p53 cDNA, called Ad-p53, was established and transduced to ARO and ARO-N cells. After incubating cells with 131I and 188Re, the survival rate of each cell line was measured using a clonogenic assay. For radionuclide gene therapy in an animal model, Ad-p53 was injected directly into ARO and ARO-N tumours which were transplanted to nude mice. Two days later, 188Re or saline was injected intraperitoneally into the mice, and the tumours were measured using a calliper for 4 weeks.ResultsIn ARO-N cells, the uptakes of 125I and 188Re were 505.16±21.30 pmol/106 cells and 13,875.20±504.85 cpm/106 cells at 30 min, respectively. There was no difference between the survival rates of ARO cells and ARO-N cells after incubation with 131I or 188Re. When Ad-p53 was transduced to ARO-N cells, the survival rate of wt-p53-expressing ARO-N cells incubated with 131I (18.5 MBq/5 ml) and 188Re (18.5 MBq/5 ml) decreased to 48.8±18.4% and 32.6±23.5%, respectively. In the nude mice experiment, ARO and ARO-N tumours gradually grew up to six to eight times larger than the initial volume. ARO and ARO-N tumours transduced with Ad-p53 continued to grow. However, the ARO-N tumours treated with Ad-p53 and 185 MBq of 188Re regressed to 20% of the initial volume.ConclusionGrowth of ARO-N tumour treated with 131I or 188Re was significantly inhibited by Ad-p53 transduction in vivo as well as in vitro. Transfection of the NIS gene into human anaplastic thyroid cancer induced the accumulation of beta-emitter radionuclides, and cotransfection with a wt-p53 gene enhanced the cytotoxic effect.
25 schema:genre article
26 schema:isAccessibleForFree false
27 schema:isPartOf N10342ae5d2b94768ac50e3848f4d71db
28 Nb1fc3b5472324b6fa1fca5679d426b4a
29 sg:journal.1297401
30 schema:keywords ARO cells
31 CMV promoter
32 ConclusionGrowth
33 MBq
34 NIS gene
35 PurposeTo
36 accumulation
37 adenovirus 5 vector
38 anaplastic thyroid cancer
39 anaplastic thyroid carcinoma cells
40 animal models
41 assays
42 beta-emitter radionuclides
43 cDNA
44 caliper
45 cancer
46 cancer cells
47 cancer model
48 carcinoma cells
49 cell lines
50 cells
51 clonogenic assay
52 cotransfection
53 cytotoxic effects
54 days
55 differences
56 effect
57 experiments
58 gene therapy
59 genes
60 human anaplastic thyroid cancer
61 human anaplastic thyroid carcinoma cells
62 incubation
63 initial volume
64 lines
65 liposomes
66 mice
67 min
68 model
69 mouse experiments
70 mutant p53
71 nude mice
72 nude mice experiments
73 p53
74 p53 gene
75 pmol/106 cells
76 promoter
77 radionuclide gene therapy
78 radionuclides
79 rate
80 recombinant adenovirus-5 vector
81 role
82 role of p53
83 saline
84 sodium iodide symporter
85 survival rate
86 symporter
87 therapy
88 thyroid cancer
89 thyroid cancer model
90 thyroid carcinoma cells
91 time
92 transduction
93 transfection
94 tumors
95 uptake
96 uptake of 125I
97 vector
98 vivo
99 volume
100 weeks
101 wild-type cell lines
102 wild-type p53
103 wild-type p53 gene
104 wt-p53 cDNA
105 wt-p53 gene
106 schema:name Wild-type p53 enhances the cytotoxic effect of radionuclide gene therapy using sodium iodide symporter in a murine anaplastic thyroid cancer model
107 schema:pagination 235-241
108 schema:productId N60caca41459f4caebede5b58c453e15a
109 Na6d14d0a5a4c440ba24bc03b2a09b372
110 Nb486b548083e48b6ae7b48fe9dfff3a0
111 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044717502
112 https://doi.org/10.1007/s00259-009-1251-5
113 schema:sdDatePublished 2022-11-24T20:54
114 schema:sdLicense https://scigraph.springernature.com/explorer/license/
115 schema:sdPublisher N2e62960ccc79489f8afde59c5b7258eb
116 schema:url https://doi.org/10.1007/s00259-009-1251-5
117 sgo:license sg:explorer/license/
118 sgo:sdDataset articles
119 rdf:type schema:ScholarlyArticle
120 N002d8c6701ea49a8a20d947db2672774 rdf:first sg:person.01356373637.49
121 rdf:rest N6edd2b9ea7f34340852cde49b40b73a9
122 N0fe93e41454b4c3b83b8760c8ecf53af rdf:first sg:person.0751347234.39
123 rdf:rest N002d8c6701ea49a8a20d947db2672774
124 N10342ae5d2b94768ac50e3848f4d71db schema:volumeNumber 37
125 rdf:type schema:PublicationVolume
126 N17d21ba2caad4be2a3f83be10952812d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Thyroid Neoplasms
128 rdf:type schema:DefinedTerm
129 N2e62960ccc79489f8afde59c5b7258eb schema:name Springer Nature - SN SciGraph project
130 rdf:type schema:Organization
131 N39e9d98b0a78468d9f4a762fec79b692 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Treatment Outcome
133 rdf:type schema:DefinedTerm
134 N45800758971c490da8375cf7d21dc9aa rdf:first sg:person.0724572466.08
135 rdf:rest N0fe93e41454b4c3b83b8760c8ecf53af
136 N60caca41459f4caebede5b58c453e15a schema:name dimensions_id
137 schema:value pub.1044717502
138 rdf:type schema:PropertyValue
139 N6edd2b9ea7f34340852cde49b40b73a9 rdf:first sg:person.01301360400.94
140 rdf:rest Na02a1ccac7b54b91b628b070e26b8c13
141 N71139fd63cd94f33af658932537a60ff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Disease Models, Animal
143 rdf:type schema:DefinedTerm
144 N7125324fadab489f939f73556b33467f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Mice
146 rdf:type schema:DefinedTerm
147 N76b0d495090f43fd9d9e46540776d592 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Mice, Nude
149 rdf:type schema:DefinedTerm
150 N7d452eeb35914675b705436e4701c153 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Genetic Therapy
152 rdf:type schema:DefinedTerm
153 N83d34eaf4ee142da8140f03476b0ed50 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Combined Modality Therapy
155 rdf:type schema:DefinedTerm
156 N9d35fb1ce61f4788b2651e91be476fd2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Radioisotopes
158 rdf:type schema:DefinedTerm
159 Na02a1ccac7b54b91b628b070e26b8c13 rdf:first Nb88721295f8843a6966b1c06e8526a3f
160 rdf:rest Ne47e4d9eebc44ff199fbe93c9daeb930
161 Na20eabbf057941be94d0f4cad9d31213 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Tumor Suppressor Protein p53
163 rdf:type schema:DefinedTerm
164 Na6d14d0a5a4c440ba24bc03b2a09b372 schema:name pubmed_id
165 schema:value 19727716
166 rdf:type schema:PropertyValue
167 Na7eb52409bda4ba1b09bb86925aa3313 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Symporters
169 rdf:type schema:DefinedTerm
170 Nb1fc3b5472324b6fa1fca5679d426b4a schema:issueNumber 2
171 rdf:type schema:PublicationIssue
172 Nb486b548083e48b6ae7b48fe9dfff3a0 schema:name doi
173 schema:value 10.1007/s00259-009-1251-5
174 rdf:type schema:PropertyValue
175 Nb88721295f8843a6966b1c06e8526a3f schema:affiliation grid-institutes:grid.31501.36
176 schema:familyName Lee
177 schema:givenName Dong Soo
178 rdf:type schema:Person
179 Nc28c5ac947504b4d9861fb9a980cb1d8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Cell Line, Tumor
181 rdf:type schema:DefinedTerm
182 Nd4d611619caa4d468151c951df8536f2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Radiopharmaceuticals
184 rdf:type schema:DefinedTerm
185 Ne47d9f0d996b49679dd6620f1de8172e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
186 schema:name Humans
187 rdf:type schema:DefinedTerm
188 Ne47e4d9eebc44ff199fbe93c9daeb930 rdf:first sg:person.01337220140.25
189 rdf:rest rdf:nil
190 Nfeb393c7726c486595284665886b8ad3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
191 schema:name Animals
192 rdf:type schema:DefinedTerm
193 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
194 schema:name Medical and Health Sciences
195 rdf:type schema:DefinedTerm
196 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
197 schema:name Oncology and Carcinogenesis
198 rdf:type schema:DefinedTerm
199 sg:journal.1297401 schema:issn 1619-7070
200 1619-7089
201 schema:name European Journal of Nuclear Medicine and Molecular Imaging
202 schema:publisher Springer Nature
203 rdf:type schema:Periodical
204 sg:person.01301360400.94 schema:affiliation grid-institutes:grid.31501.36
205 schema:familyName Jeong
206 schema:givenName Jae Min
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01301360400.94
208 rdf:type schema:Person
209 sg:person.01337220140.25 schema:affiliation grid-institutes:grid.31501.36
210 schema:familyName Lee
211 schema:givenName Myung Chul
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01337220140.25
213 rdf:type schema:Person
214 sg:person.01356373637.49 schema:affiliation grid-institutes:grid.415464.6
215 schema:familyName Kang
216 schema:givenName Joo Hyun
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01356373637.49
218 rdf:type schema:Person
219 sg:person.0724572466.08 schema:affiliation grid-institutes:grid.415464.6
220 schema:familyName Lee
221 schema:givenName Yong Jin
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0724572466.08
223 rdf:type schema:Person
224 sg:person.0751347234.39 schema:affiliation grid-institutes:grid.31501.36
225 schema:familyName Chung
226 schema:givenName June-Key
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0751347234.39
228 rdf:type schema:Person
229 sg:pub.10.1038/bjc.1996.101 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004010544
230 https://doi.org/10.1038/bjc.1996.101
231 rdf:type schema:CreativeWork
232 sg:pub.10.1038/sj.bjc.6602622 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011707440
233 https://doi.org/10.1038/sj.bjc.6602622
234 rdf:type schema:CreativeWork
235 sg:pub.10.1038/sj.cgt.7700354 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022464572
236 https://doi.org/10.1038/sj.cgt.7700354
237 rdf:type schema:CreativeWork
238 sg:pub.10.1038/sj.cgt.7700525 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001518423
239 https://doi.org/10.1038/sj.cgt.7700525
240 rdf:type schema:CreativeWork
241 grid-institutes:grid.31501.36 schema:alternateName Cancer Research Institute, Seoul National University College of Medicine, 28 Yungun-dong, 110-744, Chongno-gu, Seoul, Korea
242 Department of Nuclear Medicine, Seoul National University College of Medicine, 28 Yungun-dong, 110-744, Chongno-gu, Seoul, Korea
243 Tumor Immunity Medical Research Center, Seoul National University College of Medicine, 28 Yungun-dong, 110-744, Chongno-gu, Seoul, Korea
244 schema:name Cancer Research Institute, Seoul National University College of Medicine, 28 Yungun-dong, 110-744, Chongno-gu, Seoul, Korea
245 Department of Nuclear Medicine, Seoul National University College of Medicine, 28 Yungun-dong, 110-744, Chongno-gu, Seoul, Korea
246 Tumor Immunity Medical Research Center, Seoul National University College of Medicine, 28 Yungun-dong, 110-744, Chongno-gu, Seoul, Korea
247 rdf:type schema:Organization
248 grid-institutes:grid.415464.6 schema:alternateName Molecular Imaging Research Center, Korea Institute of Radiological and Medical Sciences, 75 Nowon-gil, Gongneung-Dong, 139-706, Nowon-Gu, Seoul, Korea
249 schema:name Cancer Research Institute, Seoul National University College of Medicine, 28 Yungun-dong, 110-744, Chongno-gu, Seoul, Korea
250 Department of Nuclear Medicine, Seoul National University College of Medicine, 28 Yungun-dong, 110-744, Chongno-gu, Seoul, Korea
251 Molecular Imaging Research Center, Korea Institute of Radiological and Medical Sciences, 75 Nowon-gil, Gongneung-Dong, 139-706, Nowon-Gu, Seoul, Korea
252 Tumor Immunity Medical Research Center, Seoul National University College of Medicine, 28 Yungun-dong, 110-744, Chongno-gu, Seoul, Korea
253 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...